Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

By J. Teerlink, G. Cotter, B. Davison, G. Felker, Gerasimos Filippatos, B. Greenberg, P. Ponikowski, E. Unemori, A. Voors, K. Adams and 14 more. The Lancet, 2013

887 citations recorded by the source corpus.

Subfields: Molecular Biology, Occupational Therapy, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/ddba54113a201aaeef3a49ce880e49de7a694a7e